List of SBIR/STTR awards granted to Isolere Bio, Inc
Isolere Bio, IncName | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to Isolere Bio, Inc in September, 2021 for $255,516.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43GM143975-01 | Phase I | 255,516 | September 15, 2021 | |||||||
A SBIR Phase I contract was awarded to Isolere Bio, Inc in August, 2018 for $223,951.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43GM128557-01 | Phase I | 223,951 | August 1, 2018 | |||||||
A SBIR Phase II contract was awarded to Isolere Bio, Inc in August, 2019 for $778,207.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44GM128557-02 | Phase II | 778,207 | August 1, 2019 | |||||||
A SBIR Phase I contract was awarded to Isolere Bio, Inc in May, 2021 for $224,890.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44GM139503-01A1 | Phase I | 224,890 | May 5, 2021 | |||||||
A SBIR Phase I contract was awarded to Isolere Bio, Inc in February, 2022 for $255,556.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43GM144018-01A1 | Phase I | 255,556 | February 1, 2022 | |||||||
A SBIR Phase II contract was awarded to Isolere Bio, Inc in May, 2022 for $735,839.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 4R44GM139503-02 | Phase II | 735,839 | May 1, 2022 | |||||||
A SBIR Phase II contract was awarded to Isolere Bio, Inc in March, 2022 for $902,504.0 USD from the National Science Foundation. | SBIR | 2132838 | Phase II | 902,504 | March 1, 2022 | |||||||
A SBIR Phase I contract was awarded to Isolere Bio, Inc in February, 2019 for $225,000.0 USD from the National Science Foundation. | SBIR | 1843074 | Phase I | 225,000 | February 1, 2019 |
